EUVIMEDEUVIMED entdecken
Open Access

Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy

Guoqing Zhao iD, Te Zhang, Jiannan Li, Longyun Li, Peng Chen, Chunlu Zhang, Kai Li, Cancan Cui

American Journal of Physiology-Cell Physiology · 01.01.2024 · 326 (1) · C214-C228

DOI: 10.1152/ajpcell.00276.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.01.2024. Verfasst von Guoqing Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China. Hauptthemen laut MEDLINE: Mitophagy, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: | Jilin Provincial Scientific and Technological Development Program (Jilin Scientific and Technological Development Program), | Natural Science Foundation of Jilin Province (Jilin Natural Science Foundation), 吉林省科学技术厅 | Jilin Provincial Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article discusses the effects and mechanisms of Parkin-mediated mitophagy in oxaliplatin-induced peripheral nerve pain (OIPNP) from both in vivo and in vitro. We believe that our study makes a significant contribution to the literature because OIPNP has always been the focus of clinical medicine, and mitochondrial quality regulation mechanisms especially Parkin-mediated mitophagy, have been deeply studied in recent years. We use a variety of molecular biological techniques and animal experiments to support our argument.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyPeripheral Nervous System DiseasesRatsAnimalsOxaliplatinReactive Oxygen SpeciesPainUbiquitin-Protein Ligases

Stichwörter der Autor:innen

Parkinmitophagyoxaliplatinperipheral nerve painsalidroside

Substanzen

OxaliplatinReactive Oxygen SpeciesUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Anesthesiology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
  • Department of Plastic and Reconstructive Microsurgery, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
  • Radiology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.

ORCID-Profile: Guoqing Zhao

Förderung

  • | Jilin Provincial Scientific and Technological Development Program (Jilin Scientific and Technological Development Program)
  • | Natural Science Foundation of Jilin Province (Jilin Natural Science Foundation)
  • 吉林省科学技术厅 | Jilin Provincial Scientific and Technological Development Program
  • 吉林省科学技术厅 | Natural Science Foundation of Jilin Province

Zitieren

APA

Zhao, G., Zhang, T., Li, J., Li, L., Chen, P., Zhang, C., Li, K., & Cui, C. (2024). Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy. American Journal of Physiology-Cell Physiology, 326(1), C214-C228. https://doi.org/10.1152/ajpcell.00276.2023

Vancouver

Zhao G, Zhang T, Li J, Li L, Chen P, Zhang C, et al. Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy. American Journal of Physiology-Cell Physiology. 2024;326(1):C214-C228. doi:10.1152/ajpcell.00276.2023

BibTeX
@article{Zhao2024,
  author = {Zhao, Guoqing and Zhang, Te and Li, Jiannan and Li, Longyun and Chen, Peng and Zhang, Chunlu and Li, Kai and Cui, Cancan},
  title = {Parkin-mediated mitophagy is a potential treatment for oxaliplatin-induced peripheral neuropathy},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  volume = {326},
  number = {1},
  pages = {C214--C228},
  doi = {10.1152/ajpcell.00276.2023}
}
Kostenlos starten →